Akero Therapeutics
AKRO
AKRO
162 hedge funds and large institutions have $2.65B invested in Akero Therapeutics in 2022 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 69 increasing their positions, 41 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
11% more funds holding
Funds holding: 146 → 162 (+16)
2% less call options, than puts
Call options by funds: $54.4M | Put options by funds: $55.7M
5.84% less ownership
Funds ownership: 109.88% → 104.03% (-5.8%)
Holders
162
Holding in Top 10
8
Calls
$54.4M
Puts
$55.7M
Top Buyers
| 1 | +$107M | |
| 2 | +$57.1M | |
| 3 | +$51.4M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$41.2M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$38.5M |
Top Sellers
| 1 | -$286M | |
| 2 | -$106M | |
| 3 | -$89.7M | |
| 4 |
YCM
Yiheng Capital Management
San Francisco,
California
|
-$34.5M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$26.9M |